Cargando…

COVID-19 and Cardiomyopathy in African Americans: An Early Single-Center Experience

Introduction The 2019 coronavirus pandemic has taken a toll on our society. Although most patients report minimal symptoms, a small proportion of patients have reported significant respiratory symptoms that led to admission to the inpatient medical ward or even the intensive care unit. Complications...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Ammar, Assaf, Andrew D, Khamooshi, Navid, Brannan, Grace D, Saba, Souheil, Zughaib, Marcel E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239070/
https://www.ncbi.nlm.nih.gov/pubmed/37273379
http://dx.doi.org/10.7759/cureus.38529
_version_ 1785053422112735232
author Ahmed, Ammar
Assaf, Andrew D
Khamooshi, Navid
Brannan, Grace D
Saba, Souheil
Zughaib, Marcel E
author_facet Ahmed, Ammar
Assaf, Andrew D
Khamooshi, Navid
Brannan, Grace D
Saba, Souheil
Zughaib, Marcel E
author_sort Ahmed, Ammar
collection PubMed
description Introduction The 2019 coronavirus pandemic has taken a toll on our society. Although most patients report minimal symptoms, a small proportion of patients have reported significant respiratory symptoms that led to admission to the inpatient medical ward or even the intensive care unit. Complications and long-term sequela of COVID-19 are still being reported and studied. The presence of cardiomyopathy, whether established or new-onset and its effect on inpatient mortality, admission to the intensive care unit or length of stay hasn’t been studied.  Methods All inpatient hospitalizations in our database between March 1, 2020, and April 30, 2020, due to COVID-19 were reviewed. Patients who had at least a limited echocardiogram during this time were included in the study if they were above the age of 18. Patients were then assigned to three groups. The first group had patients with normal left ventricular systolic function. The second group had established cardiomyopathy that persisted throughout admission. The third group had patients who were found to have new-onset cardiomyopathy during admission.  Results The inpatient mortality, although high and variable, wasn’t significantly different between the three groups. Also, there was no significant difference between admission to the intensive care unit, disposition at discharge, or oxygenation status at 24 hours between the three groups. The length of stay in the established cardiomyopathy group was markedly lower, and we suspect that could be due to more aggressive discussions about end-of-life care.  Conclusion Early COVID-19 experience at our center revealed a relatively high mortality rate that was primarily due to respiratory failure. The presence of established or new cardiomyopathy didn’t appear to alter the outcomes significantly early in the pandemic. 
format Online
Article
Text
id pubmed-10239070
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-102390702023-06-04 COVID-19 and Cardiomyopathy in African Americans: An Early Single-Center Experience Ahmed, Ammar Assaf, Andrew D Khamooshi, Navid Brannan, Grace D Saba, Souheil Zughaib, Marcel E Cureus Cardiology Introduction The 2019 coronavirus pandemic has taken a toll on our society. Although most patients report minimal symptoms, a small proportion of patients have reported significant respiratory symptoms that led to admission to the inpatient medical ward or even the intensive care unit. Complications and long-term sequela of COVID-19 are still being reported and studied. The presence of cardiomyopathy, whether established or new-onset and its effect on inpatient mortality, admission to the intensive care unit or length of stay hasn’t been studied.  Methods All inpatient hospitalizations in our database between March 1, 2020, and April 30, 2020, due to COVID-19 were reviewed. Patients who had at least a limited echocardiogram during this time were included in the study if they were above the age of 18. Patients were then assigned to three groups. The first group had patients with normal left ventricular systolic function. The second group had established cardiomyopathy that persisted throughout admission. The third group had patients who were found to have new-onset cardiomyopathy during admission.  Results The inpatient mortality, although high and variable, wasn’t significantly different between the three groups. Also, there was no significant difference between admission to the intensive care unit, disposition at discharge, or oxygenation status at 24 hours between the three groups. The length of stay in the established cardiomyopathy group was markedly lower, and we suspect that could be due to more aggressive discussions about end-of-life care.  Conclusion Early COVID-19 experience at our center revealed a relatively high mortality rate that was primarily due to respiratory failure. The presence of established or new cardiomyopathy didn’t appear to alter the outcomes significantly early in the pandemic.  Cureus 2023-05-04 /pmc/articles/PMC10239070/ /pubmed/37273379 http://dx.doi.org/10.7759/cureus.38529 Text en Copyright © 2023, Ahmed et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Ahmed, Ammar
Assaf, Andrew D
Khamooshi, Navid
Brannan, Grace D
Saba, Souheil
Zughaib, Marcel E
COVID-19 and Cardiomyopathy in African Americans: An Early Single-Center Experience
title COVID-19 and Cardiomyopathy in African Americans: An Early Single-Center Experience
title_full COVID-19 and Cardiomyopathy in African Americans: An Early Single-Center Experience
title_fullStr COVID-19 and Cardiomyopathy in African Americans: An Early Single-Center Experience
title_full_unstemmed COVID-19 and Cardiomyopathy in African Americans: An Early Single-Center Experience
title_short COVID-19 and Cardiomyopathy in African Americans: An Early Single-Center Experience
title_sort covid-19 and cardiomyopathy in african americans: an early single-center experience
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239070/
https://www.ncbi.nlm.nih.gov/pubmed/37273379
http://dx.doi.org/10.7759/cureus.38529
work_keys_str_mv AT ahmedammar covid19andcardiomyopathyinafricanamericansanearlysinglecenterexperience
AT assafandrewd covid19andcardiomyopathyinafricanamericansanearlysinglecenterexperience
AT khamooshinavid covid19andcardiomyopathyinafricanamericansanearlysinglecenterexperience
AT brannangraced covid19andcardiomyopathyinafricanamericansanearlysinglecenterexperience
AT sabasouheil covid19andcardiomyopathyinafricanamericansanearlysinglecenterexperience
AT zughaibmarcele covid19andcardiomyopathyinafricanamericansanearlysinglecenterexperience